KOLMAR KOREA CO.,LTD
Founded and listed on KOSPI in 2012 upon spin-off from the former Kolmar Korea, KOLMAR KOREA runs cosmetics ODM, prescription drugs, and packaging.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded and listed on KOSPI in 2012 via spin-off from Kolmar Korea, it runs cosmetics ODM, prescription drugs, and packaging. Over 95% of cosmetics revenue is ODM; HK inno.N makes drugs for circulatory, diabetes, cancer, and kidney conditions, while Yonwoo supplies cosmetics containers split about 50/50 domestic/export. HK inno.N develops IN-114199, IN-115314, and GLP-1 drug IN-B00009.
Products & technology
- Cosmetics ODM (basic, functional, color)Cosmetics ODM manufacturing
- Prescription drugs (circulatory, diabetes, cancer, kidney) and APIsPrescription drugs and active pharmaceutical ingredients
- Pump and tube cosmetics containers (Yonwoo)Cosmetics packaging
- Condition, Heotgaesu, HongsamjinH&B health functional food
Regulatory approvals
data.go.kr4 Korean MFDS device approvals · 2008–2024
- MFDSDressing, fluid-impermeable film2024-12-24Product approval · Class 2제인 24-1175 호
- MFDSGel for medical use, non-sterilized2024-10-25Product approval · Class 1제신 24-1308 호
- MFDSDressing, fluid-impermeable film2022-05-27Product approval · Class 2제인 22-4417 호
- MFDSIrrigation unit, vaginalRevoked2008-11-25Product approval · Class 2수허 08-1159 호
Clinical trials
data.go.kr9 MFDS clinical trial authorisations · 2012–2019 (Phase 1 7 · Phase 2 2)
- Phase 1KKM-1842019-12-30
1 trial site
- Phase 1KKM-1542019-06-20
1 trial site
- Phase 1KKM-1742019-01-23
1 trial site
- Phase 1KKM-1542018-08-31
1 trial site
- Phase 1KKM-1712018-05-04
1 trial site
- Phase 1KKM-1712017-09-08
1 trial site
- Phase 1KKM-1642017-08-03
1 trial site
- Phase 2KKMDM-012013-02-25
1 trial site
- Phase 2NDM101072012-09-20
1 trial site
R&D and key agreements
Source: DART corporate disclosureIN-114199 · 만성변비치료제 · 국내 임상1상 · Developed by HK inno.N
IN-115314 · 자가면역질환 · 인체용 국내 임상2상, 동물용 국내 임상3상 · Developed by HK inno.N
IN-B00009 · 비만치료제(GLP-1) · 국내 임상3상 · Developed by HK inno.N
Companies approved for the same productsHealthcare Infrastructure
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
Manufactures biosensors for electronic medical device consumables, including ECG measurement electrodes.
Daehan Pharmaceutical, founded in 1963 and KOSDAQ-listed in 1994, manufactures intravenous fluid pharmaceuticals.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
Dongwha Pharm, founded in 1897 and KOSPI-listed in 1976, is a diversified company centered on pharmaceuticals.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Tego Science makes cell therapies Holoderm and Rosmir, and sells the 3D skin model Neoderm for CDMO and animal-alternative testing.
Founded in 2019 and KOSDAQ-listed the same year, WON TECH makes aesthetic laser, RF, and HIFU devices including Oligio and Picocare.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition